American veterans of the Vietnam War era who were exposed to the herbicide Agent Orange faced a 57% greater risk of developing Parkinson's disease and related disorders than veterans who were not exposed, according to a study of 4.9 million health records published on Monday, 16 November 2026, in the journal JAMA Neurology.
Among those with the heaviest exposure, the men who directly handled and sprayed the chemical, the likelihood of developing Parkinson's was 99% higher, said Oregon Health & Science University (OHSU), which led the research with the VA Portland Health Care System.
What the study looked at
The researchers analysed the electronic health records of 4.9 million veterans who served during the Vietnam War era, tracking diagnoses made between 1999 and 2022. They looked at two conditions: Parkinson's disease and Lewy body dementia.
According to OHSU, the analysis adjusted for other factors that could influence the result, including traumatic brain injury and frailty.
Key numbers
- Possible or presumed exposure: 44% more likely to develop Parkinson's disease and 66% more likely to develop Lewy body dementia.
- Both conditions taken together: a 57% greater risk compared with unexposed veterans.
- Direct handling and spraying: 99% more likely to develop Parkinson's.
The highest risks were seen among veterans who sprayed or handled Agent Orange as members of the Army Chemical Corps and of Operation Ranch Hand, the Air Force unit involved in the spraying, the university said.
'Catching up with history'
Co-senior author Dr Gregory Scott, associate professor of pathology at the OHSU School of Medicine and a pathologist at VA Portland, said in the university's statement: "This is the first study in veterans to identify that increased risk of Parkinson's is associated with heavier exposure to Agent Orange." He added: "We're catching up with history in a way."
Co-author Dr Lee Neilson, a neurologist who began the project at OHSU and is now at the University of Iowa, said the finding reflects what former soldiers have long suspected. "Veterans have been talking about this for years and years," he said. "I expect they will feel validated and heard with this study."
OHSU said clinicians and veterans had long presumed a connection between the chemical and the disease.
A note of caution
The work is an analysis of health records and reports a statistical association between exposure and later diagnosis. The university's statement does not describe the study's limitations, and it does not set out a biological mechanism.
Why it matters beyond veterans
Dr Scott said the result should raise awareness of the long-term risks of other pesticides and herbicides. "I think this adds weight to the idea that we ought to get on top of this and not wait 50 years for the next herbicide to be linked to neurodegenerative disease," he said.
OHSU president Dr Shereef Elnahal, who earlier served as under secretary for health at the US Department of Veterans Affairs, noted that the PACT Act of 2022 extended health-care benefits to veterans exposed to toxic substances such as Agent Orange and removed the burden of proof for those seeking care. "Veterans who put themselves in harm's way deserve to know the truth no matter how long it takes," he said.
The study, titled "Agent Orange Exposure and Diagnosis of Parkinson Disease and Related Disorders Among US Veterans", was funded by the US Department of Veterans Affairs, the Department of Defense and the National Institute on Aging, along with foundation and university awards, according to OHSU.




